Regulation of HTLV-1 and cellular gene transcription by the viral protein HBZ
病毒蛋白 HBZ 对 HTLV-1 和细胞基因转录的调节
基本信息
- 批准号:8018489
- 负责人:
- 金额:$ 25.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-02-01 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcetyltransferaseAddressAdultAffectAffinityBindingBinding SitesBiologicalBiologyBloodBreast FeedingCREB1 geneCell NucleusChildClinicalCoitusCollectionComplexConsensusDNA BindingDataDevelopmentDiagnosisDimerizationDiseaseE1A-associated p300 proteinEP300 geneFamilyGene ExpressionGene Expression Microarray AnalysisGenesGenetic TranscriptionGoalsHuman T-lymphotropic virus 1In VitroInfectionJUN geneLeucine ZippersLifeMalignant NeoplasmsMediatingMothersN-terminalNeurodegenerative DisordersOncogene DeregulationPlayProcessProteinsProvirusesRegulationRelative (related person)RepressionResearchRetroviridaeRoleT-Cell LeukemiaT-Cell ProliferationT-LymphocyteTestingTranscription Factor AP-1Transcription Regulatory ProteinViralViral ProteinsVirusVirus Latencyactivating transcription factoractivating transcription factor 1activating transcription factor 4bZIP Domainbasedimergene repressionin vivoinsightleukemiamemberpreventpromoterpublic health relevancetranscription factortransmission process
项目摘要
DESCRIPTION (provided by applicant): Human T-cell leukemia virus type 1 (HTLV-1) is a complex retrovirus that is the causative agent of a variety of clinical disorders including adult T-cell leukemia (ATL), an aggressive and often fatal malignancy of mature activated T-cells. ATL is frequently diagnosed after several decades of infection, suggesting that a long period of viral latency contributes to the development of this disease. The HTLV-1 basic leucine zipper factor (HBZ) is believed to play a role in viral latency and T-cell proliferation. This protein is localized in the nucleus and carries a basic leucine zipper (bZIP) domain that promotes protein dimerization through interactions with appropriate leucine zippers in other proteins. Cellular bZIP factors that are bound by HBZ include certain AP-1 transcription factor components (c-Jun, JunB, JunD) and members of the ATF/CREB family (ATF-1, CREB, CREM and CREB-2). Overall, interactions with HBZ are believed to repress transcription by preventing factors from binding the DNA, an effect that is correlated with the atypical basic region in the HBZ bZIP domain. We found that HBZ also binds directly to the cellular coactivators p300 and CBP, which is mediated through regions of the viral protein outside its bZIP domain. In the context of the HTLV-1 promoter, we found that binding of HBZ to both CREB and p300/CBP is essential to achieve full repression of transcription. As the HBZ gene is uniquely encoded on the minus strand at the 3' end of the provirus, its expression is not affected by this and other mechanisms of repression targeting the 5' LTR (the normal viral promoter). It is likely that the binding of HBZ to cellular bZIP factors and p300/CBP underlie its ability to deregulate expression of many cellular genes. To gain insight into the mechanisms by which HBZ affects transcription, we have evaluated its interactions with cellular transcriptional regulators and we have identified genes that it targets. We have obtained evidence that complexes formed between HBZ and ATF/CREB factors are structurally distinct from complexes formed with AP-1 factors. In addition, we found that HBZ directly targets multiple domains of p300/CBP, including the KIX, ZZ and TAZ2 domains. In this proposal we will address the functional consequences of these interactions. In Aim 1, we propose to dissect the interaction between HBZ and p300/CBP, and determine downstream effects of this interaction, including alterations in the abilities of the coactivator to interact with and/or acetylate specific cellular proteins. In Aim 2, we will compare the interaction of HBZ with ATF/CREB and AP-1 proteins. In Aim 3, we will characterize mechanisms of HBZ-mediated deregulation of cellular gene expression. We will test whether abnormal expression of specific genes underlies certain biological aspects of HTLV-1 infection that may relate to development or clinical presentations of ATL.
PUBLIC HEALTH RELEVANCE: Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus associated with an aggressive leukemia and a neurodegenerative disease. This virus encodes a viral protein, HTLV-1 bZIP factor (HBZ), which is uniquely encoded on the minus strand of the provirus and is not transcribed from the 5' LTR (the normal viral promoter). This proposal investigates how HBZ is involved in regulating viral and cellular transcription by targeting bZIP transcription factors and key coactivators required for viral and cellular transcription.
描述(由申请人提供):人T细胞白血病病毒1型(HTLV-1)是一种复杂的逆转录病毒,是多种临床疾病的病原体,包括成人T细胞白血病(ATL),一种成熟活化T细胞的侵袭性且通常致命的恶性肿瘤。ATL经常在感染数十年后被诊断出来,这表明病毒潜伏期长有助于这种疾病的发展。HTLV-1碱性亮氨酸拉链因子(HBZ)被认为在病毒潜伏期和T细胞增殖中起作用。这种蛋白质位于细胞核中,并携带碱性亮氨酸拉链(bZIP)结构域,通过与其他蛋白质中适当的亮氨酸拉链相互作用促进蛋白质二聚化。与HBZ结合的细胞bZIP因子包括某些AP-1转录因子组分(c-Jun、JunB、JunD)和ATF/CREB家族成员(ATF-1、CREB、CREM和CREB-2)。总的来说,与HBZ的相互作用被认为通过阻止因子结合DNA来抑制转录,这种作用与HBZ bZIP结构域中的非典型碱性区域相关。我们发现,HBZ也直接结合到细胞辅激活因子p300和CBP,这是通过其bZIP结构域以外的病毒蛋白区域介导的。在HTLV-1启动子的背景下,我们发现HBZ与CREB和p300/CBP的结合对于实现转录的完全抑制是必不可少的。由于HBZ基因在原病毒3'端的负链上唯一编码,因此其表达不受靶向5' LTR(正常病毒启动子)的这种和其他抑制机制的影响。HBZ与细胞bZIP因子和p300/CBP的结合可能是其解除许多细胞基因表达调控的能力的基础。为了深入了解HBZ影响转录的机制,我们评估了它与细胞转录调节因子的相互作用,并确定了它靶向的基因。我们已经获得的证据表明,HBZ和ATF/CREB因子之间形成的复合物在结构上不同于与AP-1因子形成的复合物。此外,我们发现HBZ直接靶向p300/CBP的多个结构域,包括KIX、ZZ和TAZ 2结构域。在本提案中,我们将讨论这些相互作用的功能后果。在目的1中,我们建议解剖HBZ和p300/CBP之间的相互作用,并确定这种相互作用的下游效应,包括改变的能力的辅激活剂相互作用和/或乙酰化特定的细胞蛋白。在目的2中,我们将比较HBZ与ATF/CREB和AP-1蛋白的相互作用。在目标3中,我们将描述HBZ介导的细胞基因表达失调的机制。我们将测试特定基因的异常表达是否是HTLV-1感染的某些生物学方面的基础,这些生物学方面可能与ATL的发展或临床表现有关。
公共卫生关系:人类T细胞白血病病毒1型(HTLV-1)是一种与侵袭性白血病和神经退行性疾病相关的逆转录病毒。该病毒编码一种病毒蛋白,HTLV-1 bZIP因子(HBZ),其在原病毒的负链上唯一编码,并且不从5' LTR(正常病毒启动子)转录。该提案研究了HBZ如何通过靶向bZIP转录因子和病毒和细胞转录所需的关键共激活因子参与调节病毒和细胞转录。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Isabelle Michele Lemasson其他文献
Isabelle Michele Lemasson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Isabelle Michele Lemasson', 18)}}的其他基金
A novel role of the viral protein HBZ in mediating HTLV-1 infection.
病毒蛋白 HBZ 在介导 HTLV-1 感染中的新作用。
- 批准号:
9376715 - 财政年份:2017
- 资助金额:
$ 25.83万 - 项目类别:
Regulation of HTLV-1 and cellular gene transcription by the viral protein HBZ
病毒蛋白 HBZ 对 HTLV-1 和细胞基因转录的调节
- 批准号:
7887334 - 财政年份:2010
- 资助金额:
$ 25.83万 - 项目类别:
Regulation of HTLV-1 and cellular gene transcription by the viral protein HBZ
病毒蛋白 HBZ 对 HTLV-1 和细胞基因转录的调节
- 批准号:
8206726 - 财政年份:2010
- 资助金额:
$ 25.83万 - 项目类别:
Regulation of HTLV-1 and cellular gene transcription by the viral protein HBZ
病毒蛋白 HBZ 对 HTLV-1 和细胞基因转录的调节
- 批准号:
8585035 - 财政年份:2010
- 资助金额:
$ 25.83万 - 项目类别:
Regulation of HTLV-1 and cellular gene transcription by the viral protein HBZ
病毒蛋白 HBZ 对 HTLV-1 和细胞基因转录的调节
- 批准号:
8403665 - 财政年份:2010
- 资助金额:
$ 25.83万 - 项目类别:
Mechanism of HTLV-1 Tax-mediated activation of CDK6 transcription.
HTLV-1 Tax 介导的 CDK6 转录激活机制。
- 批准号:
7659886 - 财政年份:2009
- 资助金额:
$ 25.83万 - 项目类别:
Mechanism of HTLV-1 Tax-mediated activation of CDK6 transcription.
HTLV-1 Tax 介导的 CDK6 转录激活机制。
- 批准号:
7760625 - 财政年份:2009
- 资助金额:
$ 25.83万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 25.83万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 25.83万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 25.83万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 25.83万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 25.83万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 25.83万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 25.83万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 25.83万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 25.83万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 25.83万 - 项目类别:
Research Grant